Dr. Brandon Salke, PHARM.D, Pharmacist-in-charge, Optime Care
One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance, and, ultimately,
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
Xealth’s CEO Shares Impact of Digital Health in 2020 and What’s Ahead in 2021
Mike McSherry, CEO & Co-founder of Xealth
HIT Consultant sat down with Mike McSherry, CEO, and co-founder of Seattle-based digital prescription platform Xealth to discuss digital health lessons learned in 2020 and what we can expect in 2021. As Xealth’s CEO, Mike also works with Duke Health, UPMC, Atrium Health, and The Froedtert & the Medical College of Wisconsin health network where he uses his background in digital health to connect patients and care teams outside of traditional
Read More
30 Executives Share Top Healthcare Predictions & Trends to Watch in 2021
As we close out the year, we asked several healthcare executives to share their predictions and trends for 2021.
Kimberly Powell, Vice President & General Manager, NVIDIA Healthcare
Federated Learning: The clinical community will increase their use of federated learning approaches to build robust AI models across various institutions, geographies, patient demographics, and medical scanners. The sensitivity and selectivity of these models are outperforming AI models
Read More
Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders
Donovan Quill, President and CEO, Optime Care
Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000
Read More
M&A: Philips Acquires Remote Cardiac Monitoring BioTelemetry for $2.8B
What You Should Know:
- Philips acquires BioTelemetry, a U.S. provider of
remote cardiac diagnostics and monitoring for $72.00 per share for an implied
enterprise value of $2.8 billion (approx. EUR 2.3 billion).
- With $439M in revenue in 2019, BioTelemetry annually monitors over 1 million cardiac patients remotely; its portfolio includes wearable heart monitors, AI-based data analytics, and services.
- BioTelemetry business is expected to deliver double-digit growth and improve its
Read More
Amazon Launches HealthLake for Healthcare Orgs to Aggregate & Structure Health Data
What You Should Know:
- Amazon today announced the launch of Amazon HealthLake,
a new HIPAA-eligible service enables healthcare organizations to store, tag,
index, standardize, query, and apply machine learning to analyze data at
petabyte scale in the cloud.
- Cerner, Ciox Health, Konica Minolta Precision Medicine,
and Orion Health among customers using Amazon HealthLake.
Today at AWS re:Invent, Amazon
Web Services, Inc. (AWS), an Amazon.com company today announced Amazon
Read More
Cerner Invests in Elligo to Make Clinical Trials Accessible for Health Systems of All Sizes
What You Should Know:
- Cerner announced a strategic investment in Elligo
Health Research, a leading research organization that enables clinical trials
with nationwide community-based health care practices.
- Cerner plans to expand the data and tools available in
the Cerner Learning Health Network to offer additional clinical trial resources
to community and rural hospitals and physician practices.
- Financial terms of strategic investment were not disclosed.
Cerner
Read More
NLP is Raising the Bar on Accurate Detection of Adverse Drug Events
David Talby, CTO, John Snow Labs
Each year, Adverse Drug Events (ADE) account for nearly 700,000 emergency department visits and 100,000 hospitalizations in the US alone. Nearly 5 percent of hospitalized patients experience an ADE, making them one of the most common types of inpatient errors. What’s more, many of these instances are hard to discover because they are never reported. In fact, the median under-reporting rate in one meta-analysis of 37 studies was 94 percent. This is
Read More
Medable Raises $91M for Global Decentralized Clinical Trials Platform
What You Should
Know:
Medable announced
$91 million in new funding to accelerate the life sciences industry’s shift to
digital and decentralized clinical trials, bringing Medable’s total capital
raised to more than $136M.
- Medable has played a pivotal role in enabling clinical trials during the COVID-19 pandemic, facilitating the continuation of existing research via remote care as well as accelerating the development of vaccines and therapeutics for COVID-19.
Medable,
Read More
Study: Asthma Patients Maintain High Medication Adherence Using Propeller Health’s Platform
What You Should Know:
- New study out from Propeller and Chicago's NorthShore
University HealthSystem shows that asthma patients maintain higher medication
adherence and decrease their rescue inhaler use when using a digital health
platform.
- The study looked at 100 patients recruited from
NorthShore practices, half of whom used Propeller to manage their condition and
half of whom did not.
- The treatment group maintained their high medication adherence at 68%, while the control
Read More
